News


Resident News

Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future

By JLABS

Read full story
Resident News

Pendulum launched new product, probiotic for those w/ T2 Diabetes

By JLABS

Read full story
Resident News

Nkarta files for IPO

By JLABS

Read full story
Resident News

Biotech GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Fierce 15 winner Ideaya

By JLABS

Read full story
Resident News

Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

By JLABS

Read full story
Resident News

Mammoth Biosciences On the Fast Company's 2020 World Changing Ideas Honorable Mentions

By JLABS

Read full story
Resident News

Ellis Day Product Launch & Featured on Product List in Forbes

By JLABS

Read full story
In the media

Uncovering global opportunities: a conversation with Jennifer Hamilton of Johnson & Johnson Innovation

By Highline Beta

Read full story
Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
Other news

Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials

By JLABS

Read full story
Other news

Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, announced they are entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates

By JLABS

Read full story
Other news

With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline

By JLABS

Read full story
Other news

Avrobio, announced they have completed a $60M Series B round to back their gene therapy pipeline

By JLABS

Read full story
Other news

Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease

By JLABS

Read full story
Other news

Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm for Drug Development

By JLABS

Read full story